Company / Operating Margin
Marker Therapeutics, Inc. Operating Margin History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-10567.3%
FY2019
5-year range
-10567.3% / -6271.1%
FY2018-FY2019
Trend
-68.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-10567.3% in FY2019.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, operating margin decreased 68.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | - | - |
| FY2019 | -10567.3% | -68.5% |
| FY2018 | -6271.1% | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026